The big barrier in the wider applications of nanoparticles in medicine has been removed. This follows the development of a new screening technique to select the best biocompatible nanoparticles for use in diagnosis and therapeutic tasks.
So far the screening has been hard and time-consuming with the risk of high unpredictability of the immune system’s response to such foreign molecules, hampering the expanded use of nanoparticles in the medical sector.
Now a pathbreaking screening method has been developed that is claimed to be superior in terms of speed, safety, and cost efficiency.
